Janelle Hart
Managing Editor, Custom Content
Latest From Janelle Hart
Cutiss’ Approach To Skin Engineering
CUTISS co-founder and CEO Daniela Marino shares insights with In Vivo about the future of regenerative medicine and the ongoing development of denovoSkin, a next-generation human skin graft technology.
Next-Gen ADCs: Araris CEO Highlights Potential In Linker Technology
In Vivo sat down with 2023 Rising Leader Philipp Spycher, CEO of Araris Biotech, to discuss trends in antibody-drug conjugate R&D, and how Araris hopes to disrupt today’s chemotherapy treatment paradigm with novel linker technology.
Exploring Alltrna’s Rare Disease Platform
Michelle Werner, CEO of Alltrna, sat down with In Vivo to discuss rare disease as an increasingly important area of study, innovation in the space and how the emerging biotech hopes to impact the treatment landscape.